Anges MG Inc (4563.T)

4563.T on Tokyo Stock Exchange

362JPY
27 Nov 2014
Price Change (% chg)

¥-4 (-1.09%)
Prev Close
¥366
Open
¥373
Day's High
¥378
Day's Low
¥355
Volume
1,763,200
Avg. Vol
981,578
52-wk High
¥636
52-wk Low
¥232

4563.T

Chart for 4563.T

About

AnGes MG, Inc. is mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidate... (more)

Overall

Beta: 2.23
Market Cap (Mil.): ¥19,597.24
Shares Outstanding (Mil.): 53.54
Dividend: --
Yield (%): --

Financials

  4563.T Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -84.57 -- --
ROI: -42.20 -2.35 17.27
ROE: -42.35 -3.55 18.18
Search Stocks

REFILE-TABLE-AnGes MG -9-MTH group results

(Adds company forecast) Oct 27 - AnGes MG Inc CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2014 Sep 30, 2013 Dec 31, 2014 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 281 mln

27 Oct 2014

REFILE-TABLE-AnGes MG -6-MTH group results

(Adds company forecast) Aug 7 - AnGes MG Inc CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Jun 30, 2014 Jun 30, 2013 Dec 31, 2014 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 17

07 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Shared Research Inc.
$0.00
Provider: Wright Reports
$75.00
Provider: Shared Research Inc.
$0.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks